acrolein has been researched along with alpha-synuclein in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashizume, Y; Maruyama, W; Naoi, M; Osawa, T; Riederer, P; Shamoto-Nagai, M; Yoshida, M | 1 |
| Huang, HJ; Lin, AM; Lin, HC; Lo, YL; Wang, HT; Wang, YT; Zhao, WZ | 1 |
| Acosta, G; Ambaw, A; Herr, SA; Hubers, SA; Liu, F; Pond, A; Rochet, JC; Shi, R; Strathearn, KE; Tambe, MA; Tang, J; Truong, A; Walls, E; Zheng, L | 1 |
| Acosta, G; Fernandez, J; Herr, S; Race, N; Rogers, E; Shi, R; Tang, J | 1 |
| Huang, HJ; Lin, AM; Lin, BW; Lo, YL; Shiao, YJ; Wang, HT; Yeh, TY | 1 |
5 other study(ies) available for acrolein and alpha-synuclein
| Article | Year |
|---|---|
In parkinsonian substantia nigra, alpha-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity.
Topics: Acrolein; Aged; alpha-Synuclein; Blotting, Western; Dopamine; Electrophoresis, Polyacrylamide Gel; Female; Humans; Lipid Peroxidation; Male; Melanins; Neurons; Parkinson Disease; Proteasome Endopeptidase Complex; Substantia Nigra | 2007 |
Acrolein acts as a neurotoxin in the nigrostriatal dopaminergic system of rat: involvement of α-synuclein aggregation and programmed cell death.
Topics: Acrolein; alpha-Synuclein; Animals; Cell Death; Disease Models, Animal; Dopaminergic Neurons; Encephalitis; Male; Oxidative Stress; Parkinsonian Disorders; Protein Aggregation, Pathological; Rats, Sprague-Dawley; Substantia Nigra | 2017 |
Acrolein-mediated neuronal cell death and alpha-synuclein aggregation: Implications for Parkinson's disease.
Topics: Acrolein; alpha-Synuclein; Animals; Cell Death; Cell Line; Dopamine; Dopaminergic Neurons; Oxidative Stress; Parkinson Disease; Rats; Spinal Cord Injuries; Substantia Nigra | 2018 |
Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration.
Topics: Acrolein; alpha-Synuclein; Animals; Brain Injuries, Traumatic; Corpus Striatum; Male; Parkinson Disease, Secondary; Protein Multimerization; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase | 2019 |
Neuroprotective effect of selumetinib on acrolein-induced neurotoxicity.
Topics: Acrolein; alpha-Synuclein; Animals; Apoptosis; Benzimidazoles; Cells, Cultured; Cerebral Cortex; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Necroptosis; Neurodegenerative Diseases; Neuronal Outgrowth; Neurons; Neuroprotective Agents; Primary Cell Culture; Protein Aggregates; Rats; Toxicity Tests, Acute | 2021 |